Preventative Health Flagship

CSIRO has brought together world experts in a major study to investigate Alzheimer’s disease.

CSIRO has launched a collaborative research cluster focused on establishing a ‘biobank’ of blood samples to be used in advancing research into the prediction and early diagnosis of diseases such as Alzheimer’s and cancer.

Finding biomarkers for earliest-stage colorectal cancer will help to lower mortality rates in individuals at risk of developing this disease.

Research into Australians’ attitudes to screening tests for bowel (colorectal) cancer is being undertaken by CSIRO through the Preventative Health Flagship and two South Australian universities.

Substantially reducing the millions of cases of stroke recorded worldwide every year is the focus of this collaborative CSIRO research cluster.

More than $100M has been committed to support collaborative activities with the CSIRO National Research Flagships Program. The new Flagship Collaboration Fund reflects the Australian Government's commitment to research co-operation across all sectors of industry and science.

The Food, Health and Life Science Industries Group serves large and vital sectors of the Australian economy including the agri-food industry and the human health sector.

The National Research Flagships Program is one of the largest scientific initiatives ever mounted in Australia. Clusters, which are the main element of the Flagship Collaboration Fund offer opportunities for collaborations in areas of national importance.

Improving lives, through partnerships focused on Australia's most significant challenges and opportunities.